If you can see this message, your browser does not support canvas and needs an update. Sorry. :(
Saturday, April 20, 2019 
Market Status: CLOSE
About us and Governance Investor Relations Contact
Advanced search

Market News


FARMACEUTICA REMEDIA SA - RMAH

2018 Q3 report

Release Date: 11/15/2018 6:00:09 PM

IRIS Code: A2030

PRESS

 

The Board of Directors of Farmaceutica REMEDIA S.A. presents to the shareholders of the company, investors and the public the consolidated financial results registered by our pharmaceutical company between 01.01.2018 - 30.09.2018.

General description of the financial position and of the issuer’s performances and of its branches afferent to the 3rd quarter of 2018

During the period 01.01.2018 – 30.09.2018 the commercial company Farmaceutica REMEDIA S.A. recorded the following consolidated financial results:

 

Crt. No.

Indicator

Realisations January-September 2017 (Lei)

Realisations January-September 2018 (Lei)

Evolution 2018/2017

 (%)

1.

Net sales of goods *

243.487.219

331.142.486

+ 35,99

2.

Other operating revenues

2.962.835

3.718.734

+ 25,51

3.

Total operating revenues

246.450.054

334.861.220

+ 35,87

4.

Total operating costs *

242.941.459

331.757.256

+ 36,56

5.

Operating result

3.508.595

3.103.964

- 11,53

6.

Financial result

120.046

- 33.314

- 127,75

7.

Gross result

3.628.641

3.070.650

- 15,38

  * Including commercial discounts granted/received

A repartition of net sales of goods by segment of activity is presented as follows:

 Lei

REMEDIA Pharmacies

70.088.100

21,17%

Distribution

177.771.917

53,68%

Distribution of Hospitals & Clinics

66.175.195

19,98%

Other operations

17.107.274

5,17%

Total

331.142.486

100,00 %

 Other operating revenues” mainly comprise the following categories of revenues: collected rents, marketing services, assets sales, logistic services, other services

 

 3. Financial statements on 30.09.2018 were not audited by the independent financial auditor.

4. Economic-financial indicators 30.09.2018

 

 

 

 

LIQUIDITY AND WORKING CAPITAL

FR
FRDL

 

Current liquidity                                               (Current assets / Current debts)

1,20

1,01

 

Current assets

32.167.288

227.477.501

 

Current debts

26.744.149

224.255.942

 

Degree of indebtedness                                (Borrowed capital / Equity x 100)

0%

1,56%

 

Borrowed capital*

0

64.219

 

Equity

42.009.341

4.104.055

 

Turnover speed for client debit items                     (Average customer balance /turnover*180)

46 days

109 days

 

Average customer balance

12.171.675

125.475.740

 

Net turnover

71.698.110

309.432.005

 

Turnover speed of stocks (average stock/net COGS)*180

67 days

51 days

 

Average stock

13.674.897

53.804.624

 

Net COGS

54.846.307

287.516.512

 

             

 * including financial leasing

Notes:

1) Current liquidity – indicator level reflects a good payment capacity, therefore a reduced risk for creditors, certifying that the companies are capable of covering their short-term liabilities based on receivables and cash availability. As compared to the same period of last year, the indicator positively evolved for FR (from 1,1) and has slightly degraded for FRDL (from 1,02).

2) Degree of indebtedness expresses the effectiveness of credit risk management, indicating potential financing, liquidity problems, with influences in honouring the assumed commitments. In the case of FR, there is no risk, while for FRDL, the indicator value indicates a low risk. As compared to the same period of last year, the indicator positively evolved (from 4,24%). In the calculation of this indicator, the borrowed capital comprises both bank credits, and debts from the financial leasing.

3) Turnover speed for client debit items expresses company effectiveness in collecting its receivables, respectively the number of days until the date on which debtors pay their debts to the company. Considering the dynamics of sales and the specific of collecting receivables in the distribution of drugs, we believe that the value of the indicator is a normal one for both companies, under the circumstances. The dynamics of this indicator was for FR the following: 28 days for 9 months in 2017, 28 days in the 3rd quarter for 2017 and 45 days in the 3rd quarter of 2018. In the case of FRDL we have: 113 days for 9 months in 2017, 106 days in the 3rd quarter in 2017 and 108 days in the 3rd quarter of 2018.

4) The days on hand indicator value (67, 51 days respectively) can be considered that falls within the activity specificity, exceeding the limit imposed by the internal procedures of the company (45 days) in the case of FR. In the case of FR, the indicator had the following evolution: 66 days in the first 9 months in 2017, 68 days in the 3rd quarter in 2017 and 70 days in the 3rd quarter of 2018. In FRDL we have: 36 days for 9 months in 2017, 38 days for the 3rd quarter of 2017 and 56 days for the 3rd quarter of 2018.

 

The 2018 Q3 report - full version - is available on our own website www.remedia.ro and in the link below.

 

Chairman of the Board of Administrators                                          

TARUS” Valentin Norbert TARUS e.U.                                         

by representative

 

Valentin Norbert TARUS                                                                                                                                                                                    

 



 Print

Information provided by IRIS, the news platform of the Bucharest Stock Exchange.

______________________

Bucharest Stock Exchange ("BVB") is not responsible for the content of this News item. Issuers whose financial instruments are traded on markets operated by BVB are required to report in accordance with current legal and regulatory provisions. BVB publishes these Reports as market administrator, appointed by ASF. When, for investors’ information, Reports are published, either signed by different persons, or with conflicting information, legal liability lies fully with the signatories. BVB disclaims any obligation or responsibility towards issuers or third parties, regarding the reality, completeness and accuracy of information provided by them and distributed by BVB. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.


©2016 Bucharest Stock Exchange. All rights reserved